At a glance
ClinicalIndex Comparison RecordN/ACompleted· 41 enrolled
Drug / intervention
Goserelin Acetatedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Bone Mineral Density Alterations and Correlations With Bone and Muscle Metabolism Parameters During Menstrual Cessation Due to GnRH Therapy and After Menstrual Restoration
In Brief
An observational study evaluating Goserelin Acetate for Endometriosis and 3 related conditions. Completed, enrolled 41 participants across 1 site.
Detailed Summary
The investigators aim to investigate the effect of menstrual cessation in women with endometriosis treated with GnRH analogs for 6 months on bone mineral density and bone and muscle metabolism parameters and subsequently the effects of menstrual restoration after GnRH analogs discontinuation on the above measured parameters
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsEndometriosis, Bone Density, Muscle, Bone Metabolism
CountriesGreece
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartOct 2019
First PostedDec 2019
Primary CompletionDec 2020
Study CompletionDec 2020
TodayJul 2026
First PostedDec 18, 2019
Enrollment StartOct 1, 2019
Primary CompletionDec 1, 2020
Study CompletionDec 31, 2020
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 6.5 years ago
Interventions
Goserelin Acetatedrug
Goserelin the a GnRH analog that will be administered to achieve menstrual cessation for 6 months